168 related articles for article (PubMed ID: 31478117)
21. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
22. In vitro Study of Serial Changes to Carmustine Wafers (Gliadel) with MR Imaging and Computed Tomography.
Doishita S; Shimono T; Yoneda T; Yamada E; Tsukamoto T; Takemori D; Kimura D; Tatekawa H; Sakamoto S; Miki Y
Magn Reson Med Sci; 2018 Jan; 17(1):58-66. PubMed ID: 28867760
[TBL] [Abstract][Full Text] [Related]
23. Carmustine wafer implantation for high-grade gliomas: Evidence-based safety efficacy and practical recommendations from the Neuro-oncology Club of the French Society of Neurosurgery.
Roux A; Caire F; Guyotat J; Menei P; Metellus P; Pallud J;
Neurochirurgie; 2017 Dec; 63(6):433-443. PubMed ID: 29122306
[TBL] [Abstract][Full Text] [Related]
24. The influence of carmustine wafer implantation on tumor bed cysts and peritumoral brain edema.
Hasegawa Y; Iuchi T; Sakaida T; Yokoi S; Kawasaki K
J Clin Neurosci; 2016 Sep; 31():67-71. PubMed ID: 27430412
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma.
Samis Zella MA; Wallocha M; Slotty PJ; Isik G; Hänggi D; Schroeteler J; Ewelt C; Steiger HJ; Sabel M
Acta Neurochir (Wien); 2014 Feb; 156(2):313-23. PubMed ID: 24287680
[TBL] [Abstract][Full Text] [Related]
26. Carmustine wafer implantation for supratentorial glioblastomas, IDH-wildtype in "extreme" neurosurgical conditions.
Roux A; Aboubakr O; Elia A; Moiraghi A; Benevello C; Fathallah H; Parraga E; Oppenheim C; Chretien F; Dezamis E; Zanello M; Pallud J
Neurosurg Rev; 2023 Jun; 46(1):140. PubMed ID: 37329341
[TBL] [Abstract][Full Text] [Related]
27. Advantages and Disadvantages of Combined Chemotherapy with Carmustine Wafer and Bevacizumab in Patients with Newly Diagnosed Glioblastoma: A Single-Institutional Experience.
Akiyama Y; Kimura Y; Enatsu R; Mikami T; Wanibuchi M; Mikuni N
World Neurosurg; 2018 May; 113():e508-e514. PubMed ID: 29476996
[TBL] [Abstract][Full Text] [Related]
28. Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblastoma multiforme.
Smith KA; Ashby LS; Gonzalez LF; Brachman DG; Thomas T; Coons SW; Battaglia M; Scheck A
J Neurosurg; 2008 Dec; 109 Suppl():106-17. PubMed ID: 19123896
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of carmustine wafers in combination with 6-month metronomic temozolomide and radiation therapy in newly diagnosed glioblastoma: preliminary results.
Salmaggi A; Milanesi I; Silvani A; Gaviani P; Marchetti M; Fariselli L; Solero CL; Maccagnano C; Casali C; Guzzetti S; Pollo B; Ciusani E; Dimeco F
J Neurosurg; 2013 Apr; 118(4):821-9. PubMed ID: 23350777
[TBL] [Abstract][Full Text] [Related]
30. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
[TBL] [Abstract][Full Text] [Related]
31. The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis.
Xing WK; Shao C; Qi ZY; Yang C; Wang Z
Drug Des Devel Ther; 2015; 9():3341-8. PubMed ID: 26170620
[TBL] [Abstract][Full Text] [Related]
32. Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis.
Mu F; Lucas JT; Watts JM; Johnson AJ; Daniel Bourland J; Laxton AW; Chan MD; Tatter SB
J Clin Neurosci; 2015 Mar; 22(3):561-5. PubMed ID: 25560387
[TBL] [Abstract][Full Text] [Related]
33. Tumor microenvironment after biodegradable BCNU wafer implantation: special consideration of immune system.
Shibahara I; Hanihara M; Watanabe T; Dan M; Sato S; Kuroda H; Inamura A; Inukai M; Hara A; Yasui Y; Kumabe T
J Neurooncol; 2018 Apr; 137(2):417-427. PubMed ID: 29468445
[TBL] [Abstract][Full Text] [Related]
34. Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide.
Hegi ME; Diserens AC; Godard S; Dietrich PY; Regli L; Ostermann S; Otten P; Van Melle G; de Tribolet N; Stupp R
Clin Cancer Res; 2004 Mar; 10(6):1871-4. PubMed ID: 15041700
[TBL] [Abstract][Full Text] [Related]
35. Monitoring the effects of BCNU chemotherapy Wafers (Gliadel) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla.
Dyke JP; Sanelli PC; Voss HU; Serventi JV; Stieg PE; Schwartz TH; Ballon D; Shungu DC; Pannullo SC
J Neurooncol; 2007 Mar; 82(1):103-10. PubMed ID: 17031552
[TBL] [Abstract][Full Text] [Related]
36. Carmustine wafer implantation when surgical cavity is communicating with cerebral ventricles: technical considerations on a clinical series.
Della Puppa A; Rossetto M; Ciccarino P; Denaro L; Rotilio A; d'Avella D; Scienza R
World Neurosurg; 2011; 76(1-2):156-9; discussion 67-8. PubMed ID: 21839967
[TBL] [Abstract][Full Text] [Related]
37. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
Ashby LS; Smith KA; Stea B
World J Surg Oncol; 2016 Aug; 14(1):225. PubMed ID: 27557526
[TBL] [Abstract][Full Text] [Related]
38. A multicenter randomized phase III study for newly diagnosed maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide with chemoradiotherapy alone; Japan Clinical Oncology Group Study JCOG1703 (MACS study).
Kadota T; Saito R; Kumabe T; Mizusawa J; Katayama H; Sumi M; Igaki H; Kinoshita M; Komori T; Ichimura K; Narita Y; Nishikawa R
Jpn J Clin Oncol; 2019 Dec; 49(12):1172-1175. PubMed ID: 31804699
[TBL] [Abstract][Full Text] [Related]
39. Polymeric drug delivery for the treatment of glioblastoma.
Wait SD; Prabhu RS; Burri SH; Atkins TG; Asher AL
Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii9-ii23. PubMed ID: 25746091
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up after BCNU wafer implantation in patients with newly diagnosed glioblastoma.
Shibahara I; Miyasaka K; Sekiguchi A; Ishiyama H; Inukai M; Yasui Y; Watanabe T; Sato S; Hide T; Kumabe T
J Clin Neurosci; 2021 Apr; 86():202-210. PubMed ID: 33775329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
